NIPRO JMI Pharma introduces Oral Antiviral drug Molnupiravir as Molnuva 200 mg capsule for COVID-19 treatment

NIPRO JMI Pharma has launched newly approved oral drug for COVID-19 patients, Molnupiravir, in the name of Molnuva 200 mg capsule. Molnupiravir is recommended by UK MHRA, US FDA & WHO for emergency use.

This is a prescription only medicine and can only be taken on the prescription of a registered physician.